LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.15 | 27.76 | 29 | 5906 | 0.0049 | 0.0057 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.15 | 27.76 | 1053 | 5906 | 0.1783 | 0.6003 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.15 | 27.76 | 777 | 5906 | 0.1316 | 0.5386 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.15 | 27.76 | 1340 | 5906 | 0.2269 | 0.6509 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 59.85 | 27.76 | 28 | 6062 | 0.0046 | 0.0011 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 59.85 | 27.76 | 1041 | 6062 | 0.1717 | 0.5943 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 59.85 | 27.76 | 910 | 6062 | 0.1501 | 0.5669 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 59.85 | 27.76 | 1357 | 6062 | 0.2238 | 0.6496 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.56 | 27.76 | 25 | 6217 | 0.0040 | -0.0133 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.56 | 27.76 | 1052 | 6217 | 0.1692 | 0.5929 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.56 | 27.76 | 831 | 6217 | 0.1337 | 0.5456 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 61.56 | 27.76 | 1383 | 6217 | 0.2225 | 0.6498 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.26 | 27.76 | 18 | 6465 | 0.0028 | -0.0536 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.26 | 27.76 | 1064 | 6465 | 0.1646 | 0.5899 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.26 | 27.76 | 954 | 6465 | 0.1476 | 0.5680 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.26 | 27.76 | 1397 | 6465 | 0.2161 | 0.6459 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.97 | 27.76 | 22 | 6656 | 0.0033 | -0.0290 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.97 | 27.76 | 1068 | 6656 | 0.1604 | 0.5868 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.97 | 27.76 | 954 | 6656 | 0.1433 | 0.5643 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.97 | 27.76 | 1411 | 6656 | 0.2120 | 0.6437 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 66.67 | 27.76 | 25 | 6695 | 0.0037 | -0.0131 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 66.67 | 27.76 | 1076 | 6695 | 0.1607 | 0.5875 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 66.67 | 27.76 | 899 | 6695 | 0.1343 | 0.5518 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 66.67 | 27.76 | 1438 | 6695 | 0.2148 | 0.6467 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.37 | 27.76 | 22 | 6879 | 0.0032 | -0.0288 | MN20160318_Q01 | C21 |